BrainSonix has developed and intends to manufacture and market a medical device platform based on the Company’s proprietary Low Intensity Focused Ultrasound Pulse (“LIFUP”) technology to modulate the brain function non-invasively without any harmful or irreversible effects on the brain and body.

About BrainSonix

REPAIRING THE BRAIN, TRANSFORMING LIVES

FOUNDED BY DR. ALEXANDER BYSTRITSKY

BrainSonix is a privately held company founded by Dr. Alexander Bystritsky, an inventor and renowned neuro-psychiatrist and professor at UCLA. The Company has developed and intends to manufacture and market a medical device platform based on the Company’s patented and proprietary Low Intensity Focused Ultrasound Pulsation (“LIFUP”) technology to modulate the brain function non-invasively without any harmful or irreversible effects on the brain and body.

TARGET MARKET

Our LIFUP treatment will be a viable alternative for people who do not obtain significant relief from standard treatments (e.g., medications). The products and associated services of BrainSonix intend to address the following classes of medical applications in a non-invasive and targeted manner:

Neurological – Epilepsy, Alzheimer’s, Parkinson’s and more.

Psychiatric – Anxiety and mood disorders, OCD and PTSD.

Medical – chronic pain and obesity.

Drug development, activation within the brain and delivery to the brain.